Evidence map›Paper›PMID 24043623›Full record

ArticleThe Journal of biological chemistry2013

Jun activation domain-binding protein 1 (JAB1) is required for the optimal response to interferons.

Ryuta Muromoto, Maiko Nakajima, Koki Hirashima, Toru Hirao, Shigeyuki Kon, Kazuya Shimoda, Kenji Oritani, Tadashi Matsuda

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ryuta MuromotoFrom the Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita-12 Nishi-6, Kita-Ku, Sapporo 060-0812, Japan.
Maiko Nakajima
Koki Hirashima
Toru Hirao
Shigeyuki Kon
Kazuya Shimoda
Kenji Oritani
Tadashi Matsuda
Hokkaido University · JPOsaka University · JPUniversity of Miyazaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Degradation of IFN receptor (IFNR) protein is one of the mechanisms to limit the extent of cellular responses to interferons. Tyrosine kinase 2 (TYK2), a JAK family kinase, has been reported to bind to and stabilize IFNR, indicating that TYK2 is a fundamental component of IFNR complex. Herein, we identified Jun activation domain-binding protein 1 (JAB1) as a new TYK2 binding partner and investigated its role in the regulation of IFN responses. siRNA knockdown of JAB1 resulted in suppression of IFN-induced phosphorylation of STAT proteins and their transcriptional activation. Importantly, JAB1 knockdown induced the activation of SCF ubiquitin ligase complex containing Cullin 1 (CUL1), as judged by the enhancement of covalent modification of CUL1 with the ubiquitin-like protein NEDD8, and markedly reduced the basal protein level of IFNR. In contrast, NEDD8 knockdown or inhibition of NEDD8 modification by NEDD8-activating enzyme inhibitor resulted in increased IFNR protein concomitantly with a reduction of NEDD8-modified CUL1. Furthermore, NEDD8-activating enzyme inhibitor treatment enhanced the susceptibility to IFN-α in HeLa cells. These data suggest that the NEDD8 modification pathway is involved in the proteolysis of IFNR and that JAB1 acts as a positive regulator of IFN responses by stabilizing IFNR through antagonizing the NEDD8 pathway.

Indexed as

COP9 Signalosome ComplexCullin ProteinsGene Knockdown TechniquesHeLa CellsHumansImmunologic FactorsInterferon-alphaIntracellular Signaling Peptides and ProteinsJurkat CellsNEDD8 ProteinPeptide HydrolasesProtein Processing, Post-TranslationalProteolysisReceptors, InterferonSignal TransductionSKP Cullin F-Box Protein LigasesCOP9 Signalosome ComplexCOPS5 protein, humanCullin 1Cullin ProteinsImmunologic FactorsInterferon-alphaIntracellular Signaling Peptides and ProteinsNEDD8 ProteinNEDD8 protein, humanPeptide HydrolasesReceptors, InterferonSKP Cullin F-Box Protein LigasesTYK2 KinaseTYK2 protein, humanUbiquitinsCytokineInterferonJAK KinasePost-translational ModificationProtein DegradationReceptor RegulationSignal TransductionTyrosine-Protein Kinase (Tyrosine Kinase)

Identifiers

PMID24043623
PMCPMC3829410
OpenAlexW1987123496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.